- Home
- Publications
- Publication Search
- Publication Details
Title
CCR1 as a target for multiple myeloma
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 15, Issue 9, Pages 1037-1047
Publisher
Informa Healthcare
Online
2011-05-25
DOI
10.1517/14728222.2011.586634
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamic Modulation of CCR7 Expression and Function on Naive T Lymphocytes In Vivo
- (2014) M. R. Britschgi et al. JOURNAL OF IMMUNOLOGY
- Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
- (2010) J. Rosenblatt et al. BLOOD
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
- (2010) A. K. Gandhi et al. CURRENT CANCER DRUG TARGETS
- The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
- (2010) Yanran Cao et al. EXPERIMENTAL HEMATOLOGY
- CCR2 Plays a Critical Role in Dendritic Cell Maturation: Possible Role of CCL2 and NF- B
- (2010) F. Jimenez et al. JOURNAL OF IMMUNOLOGY
- No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing—remitting multiple sclerosis patients
- (2010) R. Reuβ et al. Multiple Sclerosis Journal
- Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model
- (2010) T. Kitamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653
- (2009) Peter Norman EXPERT OPINION ON THERAPEUTIC PATENTS
- Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts*
- (2009) Cristina Vincent et al. JOURNAL OF BONE AND MINERAL RESEARCH
- CCL5/CCR5 axis promotes the motility of human oral cancer cells
- (2009) Jing-Yuan Chuang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Novel Pyrrolidine Ureas as C−C Chemokine Receptor 1 (CCR1) Antagonists
- (2009) J. Robert Merritt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
- (2009) M Roussou et al. LEUKEMIA
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4–VCAM-1 adhesion and macrophage inflammatory protein-1α and MIP-1β production
- (2008) Masahiro Abe et al. JOURNAL OF BONE AND MINERAL METABOLISM
- CCR1 knockdown suppresses human non-small cell lung cancer cell invasion
- (2008) Chang-Li Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started